Acute lymphoblastic leukaemia--a study of immunophenotypes

Area of Science:

• Immunology
• Hematology
• Oncology

Background:

• Acute lymphoblastic leukemia (ALL) is a heterogeneous lymphoid malignancy.
• Immunophenotyping is crucial for classifying ALL subtypes and guiding treatment.
• Understanding variations in ALL subtypes across different populations is important.

Purpose of the Study:

• To investigate the immunological characteristics of leukaemic blast cells in a cohort of 55 acute lymphoblastic leukemia patients.
• To compare the prevalence of different ALL subtypes (Common-ALL, Early-B-ALL, T-ALL) in children and adults with Western reports.
• To further subclassify T-cell ALL (T-ALL) cases based on thymic maturation stages.

Main Methods:

• Analysis of immunological characteristics using a panel of monoclonal antibodies.
• Application of the immunoperoxidase technique for cell surface antigen detection.
• Classification of ALL subtypes based on immunophenotypic markers.

Main Results:

• In 36 children, Common-ALL was 39% and T-ALL was 36%, differing from Western reports.
• In 19 adults, Common-ALL was 52.6%, Early-B-ALL was 21.1%, and T-ALL was 16%, aligning with Western studies.
• Thirteen T-ALL cases were subclassified into early (6), common (3), and late (4) thymocyte maturation stages based on CD8 and CD4 expression.

Conclusions:

• The immunological profile of childhood ALL in this cohort shows a notable divergence from Western populations, particularly in the higher incidence of T-ALL.
• Adult ALL subtypes align with established Western data, suggesting distinct epidemiological patterns.
• Detailed subclassification of T-ALL provides insights into thymic maturation arrest, potentially influencing prognostic assessments.